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Abstract
RNA editing is an important cellular process by which the nucleotides in a mature RNA transcript are altered to cause them
to differ from the corresponding DNA sequence. While this process yields essential transcripts in humans and other
organisms, it is believed to occur at a relatively small number of loci. The rarity of RNA editing has been challenged by a
recent comparison of human RNA and DNA sequence data from 27 individuals, which revealed that over 10,000 human
exonic sites appear to exhibit RNA-DNA differences (RDDs). Many of these differences could not have been caused by either
of the two previously known human RNA editing mechanisms—ADAR-mediated ARG substitutions or APOBEC1-mediated
CRU switches—suggesting that a previously unknown mechanism of RNA editing may be active in humans. Here, we
reanalyze these data and demonstrate that genomic sequences exist in these same individuals or in the human genome
that match the majority of RDDs. Our results suggest that the majority of these RDD events were observed due to accurate
transcription of sequences paralogous to the apparently edited gene but differing at the edited site. In light of our results it
seems prudent to conclude that if indeed an unknown mechanism is causing RDD events in humans, such events occur at a
much lower frequency than originally proposed.
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Introduction
The accurate transcription of genomic DNA into RNA is
essential for carrying out cellular processes, as RNA transcripts are
either translated into functional proteins or perform functions
directly. However, in humans [1], plant chloroplasts and
mitochondria [2], and certain viruses (e.g., [3]), there are known
cases of RNA transcripts differing from the transcribed DNA at
specific positions. For example, in humans, adenosine deaminases
acting on RNA (ADARs) replace certain adenosines (A) with
inosines, which then act as guanosines (G) during translation [4,5];
furthermore, the protein APOBEC1 causes a small number of
CRU changes [6,7,8]. Many of these RNA editing events result in
alternative proteins that are useful to the organism, and alterations
of the frequency of certain RNA editing events can negatively
affect organismal function [9].
Despite the demonstrated benefits of RNA editing events, RNA
editing is currently viewed as a relatively rare phenomenon, with
one comprehensive study identifying only several hundred ARG
changes in the human transcriptome [10]. However, a recent study
comparing RNA and DNA sequences from 27 human individuals
challengesthisview [11].Inthisstudy,Lietal.[11]discovered more
than 10,000 human exonic sites where the RNA sequences
appeared to differ from DNA sequences obtained from the same
individual. Interestingly, the majority of these RNA-DNA differ-
ences (RDDs) produce changes other than the typical ARGo r
CRU changes expected by known mechanisms of RNA editing
[6,7]. This surprising result implies that most RDDs are produced
by some as yet unknown molecular mechanism. Perhaps even more
strikingly, this study found a much larger number of modified sites
in human mRNAs (10,210) than any study to date, suggesting that
RDDs are an important contributor to transcriptomic diversity.
Li et al. [11] experimentally confirmed that many of these
modified RNA sequences do exist and sometimes result in altered
proteins, and are therefore not artifacts of sequencing error.
Furthermore, by restricting their analysis to mostly invariant sites,
they minimized the likelihood that unsampled genetic variation at
the RDD site could result in false positives; comparison with
previous studies also ensured the accuracy of their genotype calls
at each RDD site. However, the authors did not take adequate
steps to ensure that the modified RNA could have resulted from
accurate transcription of DNA somewhere else in the genome.
Their only check of the DNA sequences present in each individual
was to ensure that RNA-seq reads mapped uniquely to the
annotated human GENCODE mRNA sequences [11]. Unfortu-
nately, this step is not enough to ensure the absence of genomic
sequences matching the modified sequences. For example,
spurious RDDs would be observed if a highly similar paralog
absent from GENCODE and differing from the edited locus at the
RDD site was transcribed and translated. In this case the RNA-seq
reads supporting RDD events could be derived from sequences
other than the seemingly modified gene.
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GENCODE sequences, there are actually three different potential
sources of spurious RDDs. First, transcribed sequences paralogous
to a GENCODE gene present in the reference genome but not
included in the GENCODE predictions of protein-coding genes
would be incorrectly inferred to be an RDD if nucleotides differed
between the two sequences. Second, even ensuring that sequences
are unique in the reference genome does not ensure that they are
the result of RNA editing: paralogous sequences present in the
reference genome that contain a single-nucleotide polymorphism
in the sampled individual (such that the exact sequence is not
present in the reference genome) would also appear to be RDDs.
Finally, nucleotide differences in segregating copy number variants
[12] that are absent from the reference assembly and contain a
single nucleotide difference from their paralogous sequence in the
reference genome would also be inferred to be RDDs. In any of
these cases the paralogous sequence, if transcribed, has the
potential to confound the analysis by producing evidence of post-
transcriptional modifications where none exist. We examined both
the DNA and RNA sequences analyzed by Li et al [11], and found
that the vast majority of apparent RDD sites identified in their
study match genomic sequence and are therefore most likely the
result of accurate transcription of paralogous sequence rather than
some unknown RNA editing mechanism.
Results
In order to determine the extent to which RDD events could be
erroneously called due to transcription of paralogous sequences
matching RDD sites, we first asked whether RDD calls made by Li
et al. [11] matched sequence elsewhere in the genome by
searching their 10,210 RDD sites against the reference genome,
a step not taken in the original paper. When extracting RDD sites
and flanking sequences from the reference genome in order to
perform this search, we noticed that at 39 of these RDD sites the
reference genome exhibited the nucleotide reported by Li et al. to
be present in the mRNA but not in the genome (which we will
refer to as the ‘‘RDD nucleotide’’). This suggests that these 39
RDD events were reported in error. We then searched the
remaining 10,179 RDD sites against the reference genome (see
Materials and Methods) and found that 890 of these RDD sites
have a paralog in the reference genome that exhibits the RDD
nucleotide. The observation of RNA-DNA sequence differences at
these sites suggests that the inferred RDDs are more likely due to
transcription of these paralogous sequences than RNA alterations.
This explanation is supported by the fact that 674 (75.7%) of these
paralogs are found in transcribed regions of the genome, and 640
(71.9%) are located within an annotated gene (Materials and
Methods).
We also found that 1,316 additional RDD sites have at least one
paralog in the reference genome not containing the RDD
nucleotide. However, such paralogs could contain polymorphisms
such that the transcription of these sequences would result in the
appearance of RDDs, if the polymorphic allele not present in the
reference genome matches the RDD nucleotide. Again, this
possibility is supported by the large percentage of such paralogs
found in genes (86.5%) or transcribed regions of the genome
(86.2%). In total, RDD sites are much more likely to have a
paralog than an average human gene (80.6% of RDD sites versus
68.3% of all human genes; P,2.2610
216; Fisher’s Exact Test
using paralogy assignments from ref. [13]). In addition to paralogs
present in the reference genome, duplication polymorphisms
absent from the reference genome could also create the
appearance of RNA-DNA differences. This possibility seems
especially relevant given that 3,893 of the remaining RDD sites are
either within a duplication listed in the Database of Genomic
Variants [14] or have a paralog within such a duplication—a 1.5-
fold enrichment of RDD sites for copy number-variable regions of
the genome (P,0.001; see Materials and Methods).
For both of the above possibilities to explain the appearance of
RDDs, there must be genomic DNA present in an individual (and
not the reference genome) that matches the RDD nucleotide. We
therefore asked whether Li et al.s’ RDD calls for each individual
were matched by genomic reads from the same individual, again, a
step not taken in the original paper. Because the list of individuals
exhibiting each RDD site was not made available, we attempted to
recapitulate Li et al.’s results by mapping their RNA-seq data to a
database of transcripts containing the 10,210 RDD sites. We used
the short-read mapping program BWA [15] to map all RNA-seq
reads and applied Li et al.’s criteria for detecting RDD events and
determining which events occur in which individuals (Materials
and Methods). For most individuals, the number of RDD events
we called closely matched the corresponding number of events
found by Li et al. (compare our Supplementary Figure S1 with
Figure 1B from Li et al.—the exact number of events originally
found in each individual was not provided by the authors),
suggesting that we fairly accurately recreated their set of RDDs.
Next, we mapped genomic reads from these same individuals
available through the 1000 Genomes project [16] to these RDD
sites, and found that on average 30.5% of RDD events called in an
individual are matched by at least one genomic read from that
same individual containing the RDD nucleotide. This result
suggests that a substantial proportion of RDD sites called by Li
et al. may not be the result of some type of RNA editing event.
Instead, there are likely paralogous sequences matching the RDD
nucleotide in some or all of the 27 individuals, and these
apparently edited transcripts could be the result of transcription
of these sequences.
Given the low genomic sequencing coverage of many of the 27
individuals [16], we suspected that even more of Li et al.’s RDD
sites could have been false positives. We reasoned that if an RDD
site matched genomic sequence from any individual, whether that
individual met the criteria for exhibiting the specific RDD event or
not, the RDD site was likely not a true editing event. We therefore
examined genomic reads from all individuals to determine how
many RDD sites matched genomic sequences present in this
sample. In total, we found that 74% of RDD sites have at least one
genomic read matching the RDD nucleotide in at least one
individual. Because some of these matches could be due to simple
sequencing errors in genomic reads, we used more stringent
criteria to identify a higher-confidence set of genomic sequences,
and examined the numbers of reads not matching either the
genomic nucleotide or the RDD nucleotide to verify that se-
quencing error had a minimal impact on this analysis (Materials
and Methods). These methods found that the majority (5,666 or
55%) of the 10,210 RDD sites match genomic sequence from at
least one individual. In total, 5,900 (57.8%) of the 10,210 RDD
sites match either sequence from one of the 27 individuals or from
the human reference genome. Table S1 provides a list of the
10,210 RDDs, and whether or not we find evidence for a genomic
explanation for the event.
If RNA editing is largely restricted to ARG substitutions, and if
the 5,900 RDD sites matching genomic sequence data are truly
spurious, then the remaining 4,310 RDD sites in Li et al.’s set
should be enriched for ARG changes. This is indeed the case, as
the percentage of all RDD sites that are ARG differences
increases from 22.8% to 23.5% (P=0.013; Fisher’s Exact Test)
when RDDs matching genomic sequence are removed from the
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individual are removed, the percentage of ARG events grows to
24.5%, though this increase is not statistically significant. While
this strongly suggests that the RDDs matching genomic sequence
are spurious, a substantial number of non-ARG events remain.
This observation can be interpreted in two ways: either the
remaining RDD sites are likely true RNA editing events, or they
are also erroneous observations due to accurate transcription of
genomic sequences missed because of the relatively low coverage
of the sequences examined in our analysis. The latter interpreta-
tion is supported by Figure 1, which shows the growth in number
of RDD sites matching genomic sequence according to our criteria
when examining sequence data from additional individuals
(Materials and Methods). Extrapolating from this curve reveals
that over 90% of all 10,210 RDDs would be removed by our
analysis using sequence data of comparable quality and coverage
from 245 individuals. It therefore seems prudent to conclude that
many of the 4,310 remaining RDDs could have been observed in
error due to transcription of paralogous loci, and that the vast
majority of the 10,210 RDD sites called by Li et al. can be
explained by faithful transcription of genomic DNA.
Discussion
Our results suggest that by failing to consider the totality of
genomic data from their sample population and paralogous loci
present in the human reference genome, Li et al. [11] grossly
overestimated the amount of RNA editing in the human genome.
However, just as striking as the number of RNA-DNA differences
described in their paper was the distribution of these changes—the
vast majority of RDD sites they report are not ARGo rC RT
substitutions, and therefore could not have been caused by any
known editing mechanism. Notably, a recent study examined
DNA and RNA sequences from a different sample of 15
individuals and did not find either of these striking results [17].
Using a similar method but with more stringent criteria for
detecting RNA-DNA differences, this study reports a much
smaller number of RDD sites (1,809) with over 50% of these
due to ARG events—a distribution far more in line with
expectations based on current knowledge of RNA editing than
the results reported by Li and colleagues. Indeed, the removal of
apparently spurious RDD sites from Li et al.’s set of RDDs alters
the distribution of editing events in this direction.
Although we are not able to explain all 10,210 RDD sites using
genomic sequence, this is in large part due to inadequate sequence
coverage, as shown in Figure 1. Furthermore, a substantial fraction
of RDDs that Li et al. attempted to validate experimentally were
not confirmed. For example, of the experiments conducted to
validate RDD events, the one that attempted to confirm by far the
largest number, searching 120 RDD sites against the more than 8
million human ESTs in GenBank, confirmed only 81 (67.5%) of
these events [11]. While the failure to confirm some of the RDD
events is probably due to the difficulty in sequencing mRNAs
expressed at low levels, it is also likely that some unconfirmed
RDDs were due to sequencing error in the original RNA-seq data.
It is therefore unnecessary to invalidate each of the 10,210 RDD
sites reported by Li et al. using data from genomic DNA in order
to cast doubt on their conclusion that there is a novel and
widespread mechanism of RNA editing, at least until stronger
evidence is provided. Taken together, the results from Li et al.
[11], Ju et al. [17], and ourselves are not inconsistent with some
unknown mechanism of RNA editing acting on the human
Figure 1. The number of RDD sites eliminated increases with number of individuals examined. This graph was generated by randomly
adding an individual’s genomic sequence data to the total dataset and counting the number of RDD sites eliminated (i.e. found to match genomic
sequence) once that individual was added. This was repeated 1,000 times and the average number of eliminated RDDs was calculated for each
number of individuals. The value for zero individuals is 929 because this is the total number of RDDs that can be eliminated solely by examining the
reference genome.
doi:10.1371/journal.pone.0025842.g001
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work will be required to precisely determine the frequency of any
such editing events, if they are indeed occurring, and the
mechanism(s) responsible for these events.
Materials and Methods
Searching RDD sites against the reference genome
We extracted each of Li et al.’s 10,210 RDD sites [11] as well as
49 bp of flanking sequence on either side of the edited site from
the NCBI 36 human reference genome. 39 of these were found to
exhibit the same nucleotide in the reference genome as in the
edited state as reported by Li et al., and were excluded from
further analysis. We then used BLAT [18] to search the remain-
ing 10,171 against the reference genome using default re-
pMatch=100000 and stepSize=5. Only BLAT hits of greater than
90% identity were considered. A hit was considered to be a
paralog capable of producing a spurious signal of RNA-DNA
sequence difference if it was at least 50 bp long (the length of the
RNA-seq reads used by Li et al. [11]), and matched the nucleotide
present in edited transcripts but not the genome at the RDD site.
890 RDDs were found to have such a paralog. Hits at least 50 bp
long but not matching the edited nucleotide were considered
paralogs not exhibiting the RDD state in the reference genome.
1,316 RDDs were found to have such a paralog.
To determine whether a site paralogous to an RDD site was
found within an annotated gene, we downloaded the coordinates
of all annotated human genes from version 54 of Ensembl [19],
and determined which sites paralogous to RDDs were found
within these coordinates. Similarly, we downloaded mapping
results of 296,734 mRNA sequences to the human genome from
the UCSC genome browser [20], and determined which RDD
paralogs were found within regions matching these sequences.
Finding RDD sites or paralogous sequences in
duplication polymorphisms
To determine which RDD sites or paralogs of RDD sites were
found within regions known to have duplication polymorphisms,
we downloaded version 10 of the Database of Genomic Variants
[14]. We then examined all copy number variants exhibiting gain
alleles and found that 3893 of RDD sites or their paralogs were
found in such regions. To determine whether RDDs and their
paralogs were significantly overrepresented in copy number
variants, we replaced each of the RDD sites or paralogous sites
examined with a random position in the human genome, and
checked whether this position was found within a duplication
polymorphism. We repeated this process 1,000 times, and never
found as many random positions in duplications as RDD or
paralogous positions. Thus, RDD sites are significantly biased
toward copy-number variable regions of the human genome
exhibiting duplication alleles.
Using RNA-seq to call RDD sites
In order to determine which individuals exhibit each of the
10,210 RDD sites reported by Li et al. [11], we downloaded their
RNA-seq data and mapped these reads to a database of transcripts
containing the 10,210 sites using BWA [15]. In the original paper,
Bowtie [21] was used to map RNA reads to the GENCODE
genes. However, BWA is more accurate and allows for indels [15],
so we use it here. In any case, if RDDs are common, then their
detection should be robust to changes in alignment software.
Following Li et al. [11], we only examined reads mapping to a
given RDD site with no more than two mismatches. We then used
their criteria to determine which individuals exhibit each RDD
site. Briefly, in order for a position in an individual to be
categorized as an RDD event in which the genomic nucleotide A is
replaced with nucleotide B in the messenger RNA, Li et al. require
1) that at least 10 RNA-seq reads map to the site, 2) that at least
90% of these reads match either A or B, 3) and that of the reads
matching either A or B, at least 10% match nucleotide B.
Finding genomic reads matching RDD sites
Genomic reads from the same 27 individuals examined by Li
et al. [11] were downloaded from the 1000 Genomes Project [16]
website. These reads correspond to a mix of 454, Illumina, and
SOLiD technologies. We constructed a database of all RDDs by
extracting from the reference human genome (hg18) 49 nucleo-
tides on each side of all RDD sites, using the position and strand
information in Table S10 from Li et al. This database was indexed
for search with BWA [15], using the ‘is’ parameter for the
algorithm (option –a is). A color-space version of this database was
built for mapping of SOLiD reads. We used BWA to map the
genomic reads to this database, initially allowing up to 5
mismatches (option –n 5) and no gaps (option –o 0). Reads having
more than one mismatch other than those corresponding to the
edited nucleotide at RDD sites were eliminated from the
remainder of the analysis.
Controlling for sequencing error
We initially found that 74% of RDD sites had at least one
genomic read in at least one individual matching the edited
nucleotide. However, nearly 54.6% of RDD sites had a genomic
read matching neither the genomic nucleotide nor the edited
nucleotide, which may be due to sequencing error. Therefore, to
minimize the effect of sequencing error, we asked how many RDD
sites had at least 90% of genomic reads from an individual
matching either nucleotide A (the genomic nucleotide) or
nucleotide B (the edited nucleotide) and at least 10% of these
reads matching nucleotide B. Note that these requirements are
similar to those used by Li et al. and ourselves to call RDD sites.
(The only relevant requirement omitted for this step is that the
total coverage at a site be greater than or equal to 10, which would
greatly reduce our sensitivity given the lower coverage of the
genomic sequence data.) We found 5,666 RDD sites (55.5%)
meeting these criteria. To ensure that this approach had adequate
specificity, we also checked how often these criteria were met by
reads matching one of the other two nucleotides. In other words,
when we randomly replaced the B nucleotide of an RDD site with
one of the two nucleotides not equal to A or B and repeated our
test, we found only ,910 RDD sites (8.9%) meeting these cri-
teria (mean after 10,000 iterations). Similarly, we verified that
sequencing error was not responsible for the sizeable proportion of
RDD sites present in a given individual that were also matched by
at least one genomic read from that same individual. While on
average 30.5% of RDD events found in a given individual were
matched by a genomic read from that same individual containing
the B nucleotide, only 8.2% of RDD events matched a genomic
read having one of the other two nucleotides. It should be noted
that some reads not matching either the A or the B nucleotide may
be the result of additional polymorphisms or paralogs rather than
sequencing error. Thus, we may be overestimating the impact of
sequencing error.
Supporting Information
Figure S1 The number of RDD events found in each
individual. We called RDD sites we found using RNA-seq data
from each of the 27 individuals after performing our own mapping
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number of RDD events originally called in each individual was not
made available, the only way to compare the similarity of our
RDD calls in each individual with the original calls is by
comparing this figure to Figure 1B from Li et al [11].
(TIF)
Table S1 Detailed list of the 10,210 RDD sites.
(XLS)
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